 Seven-day administration recombinant human granulocyte colony-stimulating factor newborn rats modulation neonatal neutrophilia myelopoiesis group Streptococcus sepsis Single-pulse administration rhG-colony-stimulating factor CSF neonatal rats peripheral neutrophilia bone marrow BM neutrophil storage proliferative pools NSP NPP study prolonged effects days rhG-CSF therapy day Sprague-Dawley newborn rats equal hours IP daily days rhG-CSF phosphate-buffered saline/human serum albumin PBS/HSA RhG-CSF significant early late peripheral neutrophilia day microL day equal addition days rhG-CSF significant increase BM NSP equal depletion significant change BM NPP Seven days rhG-CSF mild increase BM CFU-GM colony formation equal significant change liver/spleen CFU-GM colonies CFU-GM proliferative rate BM liver/spleen cultures days prophylactic rhG-CSF therapy synergistic response antibiotic therapy mortality rate experimental group streptococcal sepsis GBS GvsC equal Pulse rhG-CSF hours hours GBS inoculation antibiotics survival prevent peripheral neutropenia study days prophylactic rhG-CSF therapy induces peripheral neutrophilia myeloid maturation neutrophil BM reserves immunologic enhancement neonatal host defense experimental GBS term neonatal rats